Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

592 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
Meliga E, García-García HM, Kukreja N, Daemen J, Tanimoto S, Ramcharitar S, van Mieghem CA, Sianos G, van der Ent M, van der Giessen WJ, de Feyter P, van Domburg R, Serruys PW. Meliga E, et al. Among authors: van der ent m, van domburg r, van mieghem ca, van der giessen wj. Catheter Cardiovasc Interv. 2007 Jul 1;70(1):21-5. doi: 10.1002/ccd.21100. Catheter Cardiovasc Interv. 2007. PMID: 17584913
Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.
Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Cook S, Reardon L, Moretti C, De Servi S, Palacios IF, Windecker S, Colombo A, van Domburg R, Sheiban I, Serruys PW; DELFT (Drug Eluting stent for LeFT main) Registry. Meliga E, et al. Among authors: van domburg r. J Am Coll Cardiol. 2008 Jun 10;51(23):2212-9. doi: 10.1016/j.jacc.2008.03.020. J Am Coll Cardiol. 2008. PMID: 18534266 Free article.
Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The diabetes and drug eluting stent for LeFT main registry (D-DELFT).
Meliga E, Garcia-Garcia HM, Valgimigli M, Chieffo A, Biondi-Zoccai G, Maree AO, Gonzalo N, Cook S, Cruz-Gonzalez I, Marra S, De Servi S, Palacios IF, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys PW. Meliga E, et al. Among authors: van domburg r. EuroIntervention. 2008 May;4(1):77-83. doi: 10.4244/eijv4i1a14. EuroIntervention. 2008. PMID: 19112783
The everolimus-eluting stent in real-world patients: 6-month follow-up of the X-SEARCH (Xience V Stent Evaluated at Rotterdam Cardiac Hospital) registry.
Onuma Y, Kukreja N, Piazza N, Eindhoven J, Girasis C, Schenkeveld L, van Domburg R, Serruys PW; Interventional Cardiologists of the Thoraxcenter (2000 to 2007). Onuma Y, et al. Among authors: van domburg r. J Am Coll Cardiol. 2009 Jul 14;54(3):269-76. doi: 10.1016/j.jacc.2009.05.016. J Am Coll Cardiol. 2009. PMID: 19589442 Free article.
Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries.
Onuma Y, Kukreja N, Daemen J, Garcia-Garcia HM, Gonzalo N, Cheng JM, van Twisk PH, van Domburg R, Serruys PW; Interventional Cardiologists of Thoraxcenter. Onuma Y, et al. Among authors: van twisk ph, van domburg r. JACC Cardiovasc Interv. 2009 Jul;2(7):603-10. doi: 10.1016/j.jcin.2009.03.016. JACC Cardiovasc Interv. 2009. PMID: 19628181 Free article.
592 results